Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Ampio Pharmaceuticals, Inc. (AMPE) had Free Cash Flow per Share of $-10.57 for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
-- |
|
$-8.63M |
|
-- |
|
-- |
|
$9.57M |
|
$-9.57M |
|
$0.94M |
|
$-8.63M |
|
$-8.63M |
|
$-8.63M |
|
$-8.63M |
|
$-8.63M |
|
$-8.63M |
|
$-9.57M |
|
$-9.45M |
|
0.81M |
|
0.81M |
|
$-10.66 |
|
$-10.66 |
|
Balance Sheet Financials | |
$5.74M |
|
-- |
|
-- |
|
$5.74M |
|
$2.38M |
|
-- |
|
-- |
|
$2.38M |
|
$3.36M |
|
$3.36M |
|
$3.36M |
|
0.83M |
|
Cash Flow Statement Financials | |
$-8.56M |
|
-- |
|
-- |
|
$12.65M |
|
$4.09M |
|
$-8.56M |
|
$0.16M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
2.41 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-256.90% |
|
-256.90% |
|
-150.49% |
|
-256.90% |
|
$4.03 |
|
Free Cash Flow per Share |
$-10.57 |
$-10.57 |